Shijiazhuang No.4 Pharmaceutical Group: Peritoneal Dialysis Solution Obtains Drug Production Registration Approval

Shijiazhuang No.4 Pharmaceutical Group announced that the Group has obtained a drug production registration approval from China's National Medical Products Administration for peritoneal dialysis solution, classified as Category 3 chemical drug, deemed to have passed consistency evaluation, mainly used for peritoneal dialysis in patients with chronic renal failure, and used when hypermagnesemia has not been adequately improved.